You have 9 free searches left this month | for more free features.

Microgynon®

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Contraception Trial (Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and

Completed
  • Contraception
  • Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
  • +2 more
  • (no location specified)
Feb 2, 2022

Healthy Trial (BI 456906, Microgynon®)

Not yet recruiting
  • Healthy
  • BI 456906
  • Microgynon®
  • (no location specified)
Jun 14, 2023

Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)

Active, not recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Bochum, Germany
  • +6 more
Feb 8, 2022

Healthy Trial in Mannheim (Microgynon®, BI 425809)

Recruiting
  • Healthy
  • Microgynon®
  • BI 425809
  • Mannheim, Germany
    CRS Clinical Research Services Mannheim GmbH
Jan 30, 2023

Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))

Recruiting
  • Endometriosis Ovary
  • Semarang, Central Java, Indonesia
    Kariadi Hospital
Nov 22, 2023

Therapeutic Equivalency Trial in Chennai (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Microgynon CD)

Completed
  • Therapeutic Equivalency
  • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
  • Microgynon CD
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
May 31, 2022

Migraine, Migraine;Menstrual Trial in Leiden (Ethinylestradiol/levonorgestrel, Vitamin E)

Recruiting
  • Migraine
  • Migraine;Menstrual
  • Leiden, Zuid Holland, Netherlands
    Leiden University Medical Center
Apr 6, 2022

Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)

Recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide 1.34 mg/mL
  • +4 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jan 3, 2022

Healthy Female Participants Trial in London (Padsevonil, Microgynon 30®)

Terminated
  • Healthy Female Participants
  • London, United Kingdom
    Up0035 001
Jun 22, 2021

Bioequivalence Trial in Santiago (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Levonorgestrel 15.0 mg and

Completed
  • Bioequivalence
  • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
  • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product
  • Santiago, Chile
    Innolab
Feb 8, 2021

Scleroderma, Systemic Trial in Worldwide (Microgynon, Nintedanib)

Completed
  • Scleroderma, Systemic
  • Gent, Belgium
  • +9 more
Nov 5, 2020

Endometriotic Cyst of Ovary Trial (Letrozole, Placebo)

Not yet recruiting
  • Endometriotic Cyst of Ovary
  • (no location specified)
Aug 2, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Poland, Spain (Ibrutinib, OC: Ethinylestradiol (EE) 30 mcg and Levonorgestrel

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Krakow, Poland
  • +3 more
Dec 3, 2019

Pharmacokinetics, Pharmacodynamics Trial in Moenchengladbach (laquinimod, Placebo)

Completed
  • Pharmacokinetics
  • Pharmacodynamics
  • Moenchengladbach, Germany
    Teva Investigational Site 32415
Nov 5, 2021

NSCLC Trial in Chemnitz (Microgynon, Nintedanib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Chemnitz, Germany
    Klinikum Chemnitz gGmbH
Nov 22, 2018

Clinical Trial ,Phase I Trial in Berlin (Vilaprisan (BAY 1002670), Vilaprisan Placebo, Microgynon)

Completed
  • Clinical Trial ,Phase I
  • Vilaprisan (BAY 1002670)
  • +3 more
  • Berlin, Germany
  • +1 more
Feb 27, 2019

Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

Recruiting
  • Atrial Fibrillation
  • Heart rhythm measurements with Preventicus®
  • +3 more
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Aug 28, 2023

ECMO Braile Biomédica® in COVID-19 Patients

Recruiting
  • COVID-19
  • Patients underwent cardiorespiratory support
  • Lago Sul, Brasília - DF, Brazil
    Hospital Brasília
Oct 13, 2023

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

Recruiting
  • Venous Leg Ulcer
  • Diabetic Foot
  • AQUACEL® Ag+ Extra™
  • Cutimed® Sorbact®
  • Barranquilla, Colombia
  • +13 more
May 26, 2023

Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

Recruiting
  • Dental Implants
  • Dynamic Computer Assisted Surgery
  • Freehand
  • L´hospitalet de Llobregat, Catalunya, Spain
    University of Barcelona
Aug 31, 2023

Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)

Completed
  • Carpal Tunnel Syndrome
  • KForce Sens
  • Baseline Electrıgoniometer
  • Denizli, Turkey
    Pamukkale University
Sep 14, 2023

Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical

Not yet recruiting
  • Tricuspid Regurgitation
  • Tricuspid Valve Disease
  • TricValve® Transcatheter Bicaval Valve System
  • Medical Therapy Arm
  • Cleveland, Ohio
  • +10 more
Nov 14, 2023

Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)

Recruiting
  • Vaccine-Preventable Diseases
  • +2 more
  • Oral typhoid fever vaccine
  • Oral cholera vaccine
  • Helsinki, Finland
    Meilahti Vaccine Research Center, Helsinki University Hospital
Oct 27, 2023

Observatory on Cow's Milk Protein Allergy

Not yet recruiting
  • Food Allergy
  • Pepticate® Syneo®
  • Paris, France
    Hôpital Trousseau - APHP
Oct 10, 2023